Stock data
Sun Pharmaceutical Industries$18.16
SUNPHARMA 
0.23% • 24 H
0.23% • 24 HDividend Yield:0.7%
Global Rank#399
Market Cap$43.58B
YTD Performance20.27%
P/E0.51
Revenue$5.18B
Change 7d3.30%
SP500 BenchmarkOutperform
Country🇮🇳 India
P/S8.41
Earnings$1.02B
Dividend Yield:0.7%
Main Sector
Healthcare
Sun Pharmaceutical Industries SUNPHARMA Total Debt
SUNPHARMA Total Debt in 2022: $67.48M
According to Sun Pharmaceutical Industries latest financial reports the total debt is $67.48M, an increase of 17.02% to 2022. At the end of 2022 company had $57.67M total debt. This figure represents the debts and financial obligations that Sun Pharmaceutical Industries combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Sun Pharmaceutical Industries SUNPHARMA Total Debt History from 2023 to 2022
-
Value:-
SUNPHARMA Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $67.48M | 17.02% |
| 2022 | $57.67M | -46.37% |
| 2021 | $107.52M | -55.73% |
| 2020 | $242.90M | 33.25% |
| 2019 | $182.28M | - |
View the Top Total Debt Stocks 
